Xencor (XNCR) Interest Expenses (2013 - 2026)
Xencor (XNCR) reported Interest Expenses of $4.7 million for Q1 2026, down 45.76% year-over-year from $8.7 million in Q1 2025, and down 36.09% quarter-over-quarter from $7.4 million in Q4 2025.
Xencor (XNCR) Interest Expenses (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 10 years of Interest Expenses data on file, last reported at $4.7 million in Q1 2026.
- Interest Expenses for Q1 2026 came in at $4.7 million, down 45.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.0 million (down 21.53% YoY), and the FY2025 annual result was $31.9 million, down 12.87% from the prior year.
- Interest Expenses eased to $4.7 million in Q1 2026 per XNCR's latest filing, from $7.4 million in the prior quarter.
- Over five years, Interest Expenses peaked at $9.7 million in Q1 2024 and troughed at $7000.0 in Q1 2023.
- A 4-year average of $6.1 million and a median of $7.7 million in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2026: Interest Expenses jumped 138128.57% in 2024, then slumped 45.76% in 2026.
- A 4-year view of Interest Expenses shows it stood at $6.2 million in 2023, then soared by 40.66% to $8.7 million in 2024, then declined by 15.07% to $7.4 million in 2025, then tumbled by 36.09% to $4.7 million in 2026.
- Business Quant data shows XNCR's Interest Expenses at $4.7 million in Q1 2026, $7.4 million in Q4 2025, and $7.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 4.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.70 Mn |
| Mar 31, 2026 | 4.70 Mn |
| Dec 31, 2025 | 7.35 Mn |
| Dec 31, 2025 | 7.35 Mn |
| Sep 30, 2025 | 7.67 Mn |
| Sep 30, 2025 | 7.67 Mn |
| Jun 30, 2025 | 8.24 Mn |
| Jun 30, 2025 | 8.24 Mn |
| Mar 31, 2025 | 8.67 Mn |
| Mar 31, 2025 | 8.67 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Sep 30, 2024 | 9.03 Mn |
| Sep 30, 2024 | 9.03 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 9.68 Mn |
| Mar 31, 2024 | 9.68 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Dec 31, 2023 | 6.16 Mn |